Home Share Prices Stock Picker Financial Diary UK Indices UK Industry Sectors Company Lookup Share Risers Share Fallers Broker Ratings Finance Glossary SMS Services

Share Chat Finance News Blogs Live Prices Shares Bookshop Finance Tools Members

Round table discussion - PRECIOUS METALS

Latest Share Chat

JLP. Thanks for suc-
h a thorough respon..

LGO. Crazy just get-
ting it on CBC here..

CEY. an after hours
trade of £157..

VOD. Now holds over
10% of its shares ..

SHFT. Remember what-
I told you, the wor..

SAR. No Need for ap-
ologies chap. My th..

KAZ. was watching t-
oday as i bought ea..

XEL. Its know probl-
em at all I wood ha..

CEY. again thanks h-
owsey for your well..

SOLG. after todays
erformance, its any..

Gw Pharmaceuticals Share News (GWP)

Share News for Gw Pharmaceuticals (GWP)

Share Price: 49.625

Bid: 49.25

Ask: 50.00

Change: 0.25 (+0.51%)

Spread: 0.75

Spread as %: 1.52%

Open: 49.75

High: 51.02

Low: 48.815

Yesterday’s Close: 49.375

GWP Share News

GWP ShareCast

GWP Regulatory

Glance-PRESS DIGEST - British business press - May 21

The Times QINETIQ TOUTS FOR WORK AS STAFF FEAR 1,000 JOB CUTS The management of struggling defence research company QinetiQ has held
[21 May '10]

BRIEF-GW Pharma expects UK Sativex approval by end of Q2

LONDON, May 20 (Reuters) - GW Pharmaceuticals Plc: * UK Sativex approval expected by end of Q2 * Sativex regulatory process in UK and
[20 May '10]

STOCKS NEWS UK-GW Pharma up on positive cancer drug data

STOCKS NEWS Reuters Results diary Europe Real-time Equity News UK
[23 Mar '10]

BRIEF-GW Pharma says Sativex set to move into phase III

LONDON, March 23 (Reuters) - GW Pharmaceuticals Plc: * Sativex study meets key objectives of providing data to support entry into ph
[23 Mar '10]

UPDATE 2-UK, Spain close to approving GW's cannabis drug

By Ben Hirschler LONDON, March 18 (Reuters) - A pioneering -- but much delayed -- cannabis-based medicine for multiple sclerosis is now on
[18 Mar '10]

UPDATE 1-GW says UK, Spain close to approving cannabis drug

LONDON, March 18 (Reuters) - A pioneering -- but much delayed -- cannabis-based medicine for multiple sclerosis is now on track to win regulator
[18 Mar '10]

BRIEF-GW Pharma sees Sativex cleared in UK, Spain in Q2

LONDON, March 18 (Reuters) - GW Pharmaceuticals Plc: * UK and Spanish regulators confirm no major issues outstanding re Sativex
[18 Mar '10]

UPDATE 1-GW Pharma posts FY profit

* Says Bayer to pay 10 mln stg after UK approval of Sativex * Sees becoming commercial-stage pharma company in 2010 * FY pretax
[25 Nov '09]

Datafeed and UK data supplied by NETbuilder and Interactive Data. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk!
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.